Ursodeoxycholic Acid Therapy in Chronic Heart Failure: A Placebo-Controlled Study Evaluating the Effects of Ursodeoxycholic Acid on Peripheral Blood Flow and Immune Function.

Trial Profile

Ursodeoxycholic Acid Therapy in Chronic Heart Failure: A Placebo-Controlled Study Evaluating the Effects of Ursodeoxycholic Acid on Peripheral Blood Flow and Immune Function.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 16 Jan 2017

At a glance

  • Drugs Ursodeoxycholic acid (Primary)
  • Indications Chronic heart failure
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 07 Feb 2012 Results published in the Journal of the American College of Cardiology.
    • 07 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top